COVID-19 Emerging themes: T-cell immune responses & immunoSEQ® T-MAP™ COVID applications
On-demand
Thomas Snyder
Dr Thomas Snyder is Vice President, Research for T-Detect at Adaptive Biotechnologies, where he leads the scientific program, in collaboration with Microsoft, to map T-cell receptor sequences to the antigens they bind to in order to create diagnostics for infectious disease, autoimmune diseases, and cancer.
Close
Paul Fields
Dr Paul Fields is a computational biologist with more than 10 years’ research experience and is an expert in the field of immunosequencing. He currently leads a team at Adaptive that works with academic and biopharmaceutical partners to perform data analysis and integrate immunoSEQ Data to address broader biological questions.
Close
At the beginning of 2020, few would have predicted that a global pandemic would turn our daily lives upside down. But 1 year later, the research community may have a clearer view of what might lie ahead. Throughout 2020, Adaptive Biotechnologies, along with researchers and collaborators around the world, contributed to the massive effort to understand and fight the COVID-19 pandemic. This webinar focuses on what we have learned so far, and where COVID-19 research is headed in 2021.
In this webinar, you will find out more about:
- new data and the clinical utility of signals, including disease severity, neutralizing antibody response, and data on vaccine vs. viral response;
- the new immunoSEQ® T-MAP™ COVID feature, called the Classifier, how it was developed, what this feature can tell you, and how can it be used to propel your COVID-19 research;
- the current and future research applications of the immunoSEQ T-MAP COVID tool;
- future research directions and implications of the T-cell immune response for fighting emerging SARS-CoV-2 variants.
For Research Use Only. Not for use in diagnostic procedures.
All emails contain an unsubscribe link.You can review our privacy policy, cookie policy and terms and conditions online.
